158 related articles for article (PubMed ID: 35378827)
21. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
Chen H; Takahara M; Oba J; Xie L; Chiba T; Takeuchi S; Tu Y; Nakahara T; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Oct; 64(1):39-44. PubMed ID: 21767935
[TBL] [Abstract][Full Text] [Related]
22. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
[TBL] [Abstract][Full Text] [Related]
23. NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5.
Gurri S; Siegenthaler B; Cangkrama M; Restivo G; Huber M; Saliba J; Dummer R; Blank V; Hohl D; Werner S
EMBO Mol Med; 2023 Nov; 15(11):e17761. PubMed ID: 37807968
[TBL] [Abstract][Full Text] [Related]
24. The importance of ulceration of cutaneous melanoma of the head and neck: a comparison of ear (pinna) and nonear sites.
Augenstein AC; Capello ZJ; Little JA; McMasters KM; Bumpous JM
Laryngoscope; 2012 Nov; 122(11):2468-72. PubMed ID: 23108883
[TBL] [Abstract][Full Text] [Related]
25. Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
Hintsala HR; Jokinen E; Haapasaari KM; Moza M; Ristimäki A; Soini Y; Koivunen J; Karihtala P
Anticancer Res; 2016 Apr; 36(4):1497-506. PubMed ID: 27069125
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
White I; Fortino J; Curti B; Vetto J
Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
[TBL] [Abstract][Full Text] [Related]
27. Detection of mRNA of Telomerase Protein in Benign Naevi and Melanomas Using RNAscope.
Baltzarsen PB; Georgsen JB; Nielsen PS; Steiniche T; Stougaard M
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):36-41. PubMed ID: 30095463
[TBL] [Abstract][Full Text] [Related]
28. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.
Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G
Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
32. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
[TBL] [Abstract][Full Text] [Related]
33. Metallothionein-overexpression as a prognostic marker in melanoma.
Weinlich G
G Ital Dermatol Venereol; 2009 Feb; 144(1):27-38. PubMed ID: 19218909
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
36. Loss of beta-catenin expression associated with disease progression in malignant melanoma.
Kageshita T; Hamby CV; Ishihara T; Matsumoto K; Saida T; Ono T
Br J Dermatol; 2001 Aug; 145(2):210-6. PubMed ID: 11531781
[TBL] [Abstract][Full Text] [Related]
37. Observational study on the mitotic rate and other prognostic factors in cutaneous primary melanoma arising from naevi and from melanoma de novo.
Betti R; Santambrogio R; Cerri A; Vergani R; Moneghini L; Menni S
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1738-41. PubMed ID: 24673663
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma.
Platz A; Ringborg U; Grafström E; Höög A; Lagerlöf B
Melanoma Res; 1995 Apr; 5(2):101-6. PubMed ID: 7620336
[TBL] [Abstract][Full Text] [Related]
39. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
van den Oord JJ; Maes A; Stas M; Nuyts J; De Wever I; De Wolf-Peeters C
Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
